IP Verse

Glenmark Pharmaceuticals Europe patent opposition analysis

Get complete Patent Opposition Report for Glenmark Pharmaceuticals Europe

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Glenmark Pharmaceuticals Europe

Explore patent oppositions filed by Glenmark Pharmaceuticals Europe against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3578175	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Aug 30, 2023
EP2653873	Compositions And Uses For Treating Multiple Sclerosis	BIOGEN IDEC MA	Apr 19, 2023
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Oct 12, 2022
EP2817000	Oral Pharmaceutical Compositions Of Dabigatran Etexilate	ESTEVE PHARMACEUTICALS	Apr 14, 2022
EP2478907	Methods And Compositions For Treating Cancer	COUGAR BIOTECHNOLOGY	Jan 14, 2022
EP2493466	Novel Antitumoral Use Of Cabazitaxel	AVENTIS PHARMA	Mar 10, 2021
EP3395338	Rapid Dissolution Formulation Of Cinacalcet Hcl	AMGEN	Jan 27, 2020
EP3260117	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Jan 16, 2020
EP3395339	Rapid Dissolution Formulation Of A Cinacalcet Hcl	AMGEN	Jan 16, 2020
EP3395340	Rapid Dissolution Formulation Of Cinacalcet Hcl	AMGEN	Jan 16, 2020

Top competitors of Glenmark Pharmaceuticals Europe

MUNDIPHARMA

AMGEN

EURO CELTIQUE